ZimVie Inc. (ZIMV)
NASDAQ: ZIMV · Real-Time Price · USD
13.49
+0.32 (2.43%)
Nov 20, 2024, 4:00 PM EST - Market closed

Company Description

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide.

It operates through The Dental Segment. The company offers dental implant systems; biomaterials; prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name.

It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service.

The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors.

ZimVie Inc. was incorporated in 2021 and is headquartered in Palm Beach Gardens, Florida with additional facilities around the globe.

ZimVie Inc.
ZimVie logo
Country United States
Founded 2021
Industry Medical Devices
Sector Healthcare
Employees 2,600
CEO Vafa Jamali

Contact Details

Address:
4555 Riverside Drive
Palm Beach Gardens, Florida 33410
United States
Phone 303 443 7500
Website zimvie.com

Stock Details

Ticker Symbol ZIMV
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001876588
CUSIP Number 98888T107
ISIN Number US98888T1079
SIC Code 3843

Key Executives

Name Position
Vafa Jamali President, Chief Executive Officer and Director
Richard J. Heppenstall Executive Vice President, Chief Financial Officer and Treasurer
Heather Kidwell Senior Vice President, Chief Legal, Human Resources and Compliance Officer and Corporate Secretary
Indraneel Kanaglekar Senior Vice President and Chief Commercial Officer
Sandra Schneider Chief Accounting Officer
Steve Rondeau Senior Vice President and Chief Information Officer
Ann Vu SVice President and Chief Quality and Regulatory Affairs Officer

Latest SEC Filings

Date Type Title
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 30, 2024 10-Q Quarterly Report
Oct 30, 2024 8-K Current Report
Oct 4, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Aug 1, 2024 10-Q Quarterly Report
Aug 1, 2024 8-K Current Report
Jul 2, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
May 24, 2024 SD Form - SD
May 17, 2024 8-K Current Report